(Q40722959)

23 September 2017

1 reference

title

Viral infections in leukemia and bone marrow transplant patients (English)

1 reference

23 September 2017

Wingard JR

1

1 reference

23 September 2017

1 January 1993

1 reference

23 September 2017

1 reference

23 September 2017

11 Suppl 2

1 reference

23 September 2017

115-125

1 reference

Acyclovir prophylaxis of herpes-simplex-virus infections

23 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Cytomegalovirus infections during acute childhood leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Cytomegalovirus (CMV)-Specific Intravenous Immunoglobulin for the Prevention of Primary CMV Infection and Disease after Marrow Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Infection with varicella-zoster virus after marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Acyclovir treatment of herpes zoster infections. Use in children undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Live attenuated varicella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

The risk of zoster after varicella vaccination in children with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Oral bromovinyldeoxyuridine therapy for herpes simplex and varicella-zoster virus infections in severely immunosuppressed patients: a preliminary clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Drug susceptibilities of isolates of varicella-zoster virus in a clinical study of oral brovavir

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

Live Attenuated Varicella Vaccine: Protection in Healthy Adults Compared with Leukemic Children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064271

10.3109/10428199309064271

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

8124223